sub banner

Management Team

Management Team | Research Team

Nicole

Nicole L. Wagner, PhD
President and Chief Executive Officer

Contact Email: nicole.wagner@lambdavision.com

Dr. Wagner recently obtained her PhD in Molecular and Cell Biology from the University of Connecticut under the advising of Dr. Robert Birge. Nicole entered the graduate program in 2007 and spent the majority of her graduate career working on optimizing retinal-containing proteins for application in devices. During the course of her PhD research, she played a critical role in the proof-of-concept experiments, which helped to found LambdaVision in May 2009. Through the use of site-directed mutagenesis, site-specific saturation mutagenesis, and directed evolution, Nicole was able to genetically engineer the protein, bacteriorhodopsin, for a variety of device applications, including protein-based holographic and 3-dimensional memories, a chemical detection sensor, and, most recently, a protein-based retinal implant.

Nicole is an accomplished scientist and entrepreneur with numerous peer-reviewed publications, and has presented her research at both National and International meetings. In 2012, Dr. Wagner received the Connecticut Technology Council’s Women of Innovation “Collegian Innovation and Leadership Award” for her work with LambdaVision, and most recently was listed as one of CT Magazine’s 40 under 40 for the class of 2015. Nicole currently serves as LambdaVision’s President and CEO. Since taking on the role of CEO, Dr. Wagner has been successful in securing over $1.5M in local, state, and government funding to accelerate the research, development, and commercialization of LambdaVision’s retinal implant.

Bob

Robert R. Birge, PhD
Founder

Contact Email: robert.birge@lambdavision.com

Bob Birge received his B.S. degree in chemistry from Yale University in 1968, his PhD in chemical physics from Wesleyan University in 1972, and was a National Institutes of Health postdoctoral fellow at Harvard University from 1973-1975. He was an Assistant and subsequently a tenured Associate Professor of Chemistry at the University of California, Riverside (1975-1984), and then served as Professor and Head of the Chemistry Department at Carnegie Mellon University (1984 - 1987). He joined the faculty at Syracuse University in 1988 where he was a University Professor of Chemistry and Physics, Director of the W. M. Keck Center for Molecular Electronics, and Research Director of the New York State Center for Advanced Technology in Computer Applications and Software Engineering. In January 2000, he joined the faculty at the University of Connecticut where he holds the Harold S. Schwenk Distinguished Chair in chemistry. He has published over 250 research papers and holds 5 US and international patents on the use of proteins to make holographic associative memories, three-dimensional paged memories and hybrid protein-semiconductor devices. He has served on the editorial advisory board of seven journals and was an associate Editor of Biospectroscopy. In 1997, he was listed among the fifty "Cyber Elite" by Time Digital for his work on protein-based devices, and the use of these devices for computer memories and processors. More recently, he won the Connecticut Innovations 2001 Annual Technology Award, the 2002 3M Award of Canada for Physical Chemistry and the 2009 Connecticut Medal of Science.

Jordan

Jordan A. Greco, PhD
Chief Scientific Officer

Contact Email: jordan.greco@lambdavision.com

Dr. Greco obtained his PhD in Physical Chemistry at the University of Connecticut in 2015. Under the direction of Dr. Robert Birge, Jordan's graduate thesis work primarily involved the investigation of the structure and function of photoactive proteins, using both spectroscopic and quantum mechanical approaches. Much of his work has contributed towards the application of the protein bacteriorhodopsin into photonic and biomimetic devices, such as protein-based optical memories and processors, photovoltaic cells, and the retinal implant developed by LambdaVision. Concurrent with his work on bacteriorhodopsin, Jordan has contributed to numerous computational analyses for the excited state behavior of heterocyclic conjugated compounds (e.g., porphyrin, chlorins, and corroles), carotenoids (e.g., peridinin), and other polyene-based chromophores rooted in biological systems. Dr. Greco has presented this work to international audiences and he continues to remain active in the field via several multidisciplinary collaborations.

Since joining the research group of Dr. Birge in 2009, Jordan has been actively involved in the research and development that has led to the creation of the protein-based retinal implant and the commercialization of this technology through LambdaVision. Jordan's graduate thesis work influenced the design and development of the retinal implant construct and the manufacturing techniques that are used to produce the prosthetic. As Director of Operations, Jordan is responsible for manufacturing the retinal implants and establishing standard operating procedures and quality control measures. Moreover, his research efforts helped to direct critical proof-of-concept experiments that investigated the efficacy of the retinal implant architecture.

sub banner

Home | About | Indications | Product | News | Resources
 © 2017 LambdaVision, Inc. All Rights Reserved. Website by J. A. Greco.